July 2, 2020

Volume X, Number 184

July 02, 2020

Subscribe to Latest Legal News and Analysis

July 01, 2020

Subscribe to Latest Legal News and Analysis

June 30, 2020

Subscribe to Latest Legal News and Analysis

June 29, 2020

Subscribe to Latest Legal News and Analysis

TRICARE Claims Processing Suspension

Warning: TRICARE Claims Processing Suspension May Occur During Health Care Fraud Investigations for Compounding Pharmacy Prescriptions

Yesterday, the Wall Street Journal (WSJ) reported on a significant federal investigation regarding compounding pharmacies and compound pharmaceutical prescriptions for TRICARE beneficiaries in at least four states. TRICARE, the federal health benefit program under the Defense Health Agency, provides health care benefits for more than 9.5 million current and retired members of the uniformed services and their families. TRICARE health care fraud allegations can result not only in civil and criminal sanctions, but also in TRICARE claims processing temporary suspensions, as well as provider exclusion and termination from TRICARE and other federal healthcare programs.

Health Care Fraud: Civil and Criminal Action

According to the WSJ there were four civil fraud settlements by Florida pharmacies last month that will soon be reported. These settlements – amounting to $12.8 million – are based upon allegations of falsely billing TRICARE for expensive pharmaceutical creams and gels to treat pain, scars, and other ailments. The WSJ reported that federal prosecutors are pursuing “numerous criminal investigations,” and the U.S. Attorney for the Middle District of Florida anticipates filing criminal charges in early 2016 against pharmacies, drug marketers, and physicians cited in the settlements. Separate Justice Department investigations on compounding pharmacies are ongoing in California, Mississippi, and Texas.

Earlier this year, the Military Times reported that TRICARE began a new compound pharmaceutical medication screening process in response to aggressive direct marketing campaign by compounding pharmacy marketers.1 In addition, the TRICARE program issued an article regarding TRICARE beneficiaries being targeted by call centers and others for unsolicited medical prescriptions.2 And in July, a Jacksonville-based compounding pharmacy settled with the government for $8.4 million dollars for allegations that from February 2015 to April 2015 it had sought reimbursement for compounding pharmaceutical prescriptions that were not medically necessary and were written by physicians who had never actually seen the patients.3 Clearly, the federal government has focused on alleged TRICARE abuse of compound pharmaceuticals this past year.

TRICARE Suspension, Exclusion, and Termination: A Separate Administrative Action

The federal criminal and civil investigations of compounding pharmacies are only part of the story. TRICARE health care providers who prescribed compounding pharmaceuticals may have their TRICARE claims processing temporarily suspended during the investigations. The Defense Health Agency has the administrative ability to:

  • Temporarily suspend TRICARE claims processing for a provider; and

  • Exclude or terminate a Provider from the TRICARE Program.4

These sanctions are in addition to – and not in lieu of – any other remedies or sanctions authorized by law or regulation.5

Temporary suspension of TRICARE claims processing is the first step the Defense Health Agency usually takes on allegations of health care fraud or abuse. Other steps may include administrative action to exclude or terminate the provider from the TRICARE Program. This in turn results in provider exclusion from Medicare and other federal government health care programs.

Fortunately, providers are entitled to present evidence to the Defense Health Agency rebutting allegations that led to the TRICARE claims processing temporary suspension. In addition, there are several levels of administrative procedures and appeals that take place when a provider is temporarily suspended from TRICARE claims processing and before a provider is excluded or terminated from the TRICARE program.6 Unfortunately, while the government sorts out and reviews all the information that led to the temporary suspension of TRICARE claims processing, a providers’ practice may be curtailed severely – especially if the suspension extends for 18 months, the maximum length of a TRICARE claims processing suspension.7

Providers who are either temporarily suspended or are facing exclusion or termination from the TRICARE program must carefully navigate the Defense Health Agency’s administrative process. If a provider receives a TRICARE claims processing temporary suspension notice from the Defense Health Agency, the provider should seek legal counsel to assist in responding to the Agency.

Tricare to start screening compound medications Friday
2 TRICARE Beneficiaries Being Targeted by Call Centers and Others For Unsolicited Medical Prescriptions
3 United States Settles False Claims Act Allegations Against Jacksonville-Based Compounding Pharmacy for More Than $8 Million ​
432 CFR § 199.9(f)
532 CFR § 199.9(a)(3)
632 CFR § 199.9(h)
732 CFR § 199.9(h)(1)(vi)(A)

Copyright Holland & Hart LLP 1995-2020.National Law Review, Volume V, Number 314


About this Author

Holland & Hart provides a comprehensive health law practice to assist clients in navigating the dynamic healthcare industry. In recent years, healthcare has experienced dramatic change, extraordinary competition, and increasingly complex regulation. Our experienced attorneys and staff skillfully respond to these challenges. By remaining on the forefront of healthcare law, we are able to provide coordinated services to meet the business, transactional, litigation, and regulatory needs of our clients.

Our healthcare clients include hospitals,...